Cargando…
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
BACKGROUND: Immune checkpoint inhibitors have improved clinical outcomes including survival in several malignancies but have also been associated with a range of immune-related adverse events (irAEs). Neurological irAEs are rare compared to the more typical skin, gastrointestinal, and endocrine toxi...
Autores principales: | Gao, Catherine A., Weber, Urs M., Peixoto, Aldo J., Weiss, Sarah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796437/ https://www.ncbi.nlm.nih.gov/pubmed/31623673 http://dx.doi.org/10.1186/s40425-019-0748-0 |
Ejemplares similares
-
Transient neonatal autoimmune autonomic ganglionopathy
por: Baker, Steven K., et al.
Publicado: (2014) -
Autoimmune Autonomic Ganglionopathy Presenting as Constipation
por: Ahmed, Abdelwahab, et al.
Publicado: (2022) -
Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy
por: Nakae, Yoshiki, et al.
Publicado: (2017) -
Association of Statins with Sensory and Autonomic Ganglionopathy
por: Novak, Peter, et al.
Publicado: (2015) -
Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
por: Dumitrascu, Oana M., et al.
Publicado: (2017)